查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970475

全球心内和血管内超音波市场规模、份额、趋势和成长分析报告（2026-2034）

Global Intracardiac Echocardiography and Intravascular Ultrasound Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，心臟内超音波超音波和血管内超音波的市场规模将从 2025 年的 10.2 亿美元成长到 16.8 亿美元，2026 年至 2034 年的复合年增长率为 5.62%。

心内超音波心臟检查和血管内超音波（IVUS）技术正融合成为下一代介入性心臟病学中不可或缺的影像技术。心内超音波心动图（ICE）可提供即时、高解析度的心内影像，简化复杂的结构性心臟介入手术流程。这减少了对透视的依赖，并提高了手术的精确度。 IVUS能够以亚毫米级的分辨率解析血管壁形态和斑块成分，从而在经皮冠状动脉和外周血管介入治疗过程中实现支架尺寸的选择、优化以及病变形态的评估。这些技术协同作用，基于生理引导进行影像主导的决策，创造新的手术流程，最终改善治疗效果并缩短手术时间。随着微创结构性心臟病治疗的日益普及，对整合ICE、IVUS及其他辅助影像技术的整合式影像平台的需求必将持续成长。

技术进步进一步提升了其临床效用。高频换能器、导管小型化和自适应波束形成技术的改进提高了空间解析度并缩小了导管尺寸，从而便于进入弯曲的解剖结构。融合成像、自动斑块定量和三维重建等软体技术的进步，将原始数据转化为介入性外科医生可操作的指标。此外，内建人工智慧演算法能够实现即时组织表征、分割和引导支持，从而减少操作者差异并加快术中决策。与导管室资讯系统的整合以及与机器人导航平台的互通性，将进一步巩固ICE/IVUS在现代混合手术环境中的关键地位。

商业化部署将由实证医学证据的累积和适应症的扩展所驱动。随着註册研究和随机对照试验量化了合理应用ICE/IVUS可降低辐射曝射量、手术併发症和长期血管再阻塞，预计其应用范围将从三级医疗机构扩展到社区医疗中心。纳入减少再次介入和缩短恢復时间的成本效益模型将促使支付方接受该技术，同时，旨在提升介入性心臟病专家和导管检查室团队技能的培训课程也在不断发展完善。远距教学和远端图像判读服务也蕴藏着机会。血管内影像专家的评估将有助于将先进的医疗服务扩展到资源匮乏的地区。总而言之，ICE和IVUS正从辅助设备发展成为标准的治疗影像工具，以实现更安全、更有效的血管内和结构性心臟疾病治疗。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球心内及血管内超音波市场：依应用领域划分

  • 市场分析、洞察与预测
  • 电生理治疗
  • 左心耳闭锁
  • 室间隔缺损
  • 其他的

第五章 全球心内和血管内超音波市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 导管检查室
  • 其他的

第六章 全球心内及血管内超音波市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Johnson & Johnson Services Inc.（Biosense Webster Inc.）
    • Nipro（Infraredx Inc.）
    • Conavi Medical
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE HealthCare
    • Medtronic Plc
    • Canon Medical Systems Corp
简介目录
Product Code: VMR11215985

The Intracardiac Echocardiography and Intravascular Ultrasound Market size is expected to reach USD 1.68 Billion in 2034 from USD 1.02 Billion (2025) growing at a CAGR of 5.62% during 2026-2034.

Intracardiac echocardiography and intravascular ultrasound technologies are converging as indispensable imaging modalities for next-generation interventional cardiology. ICE provides real-time, high-resolution intracardiac views that streamline complex structural heart interventions-reducing reliance on fluoroscopy and improving procedural precision. IVUS offers sub-millimeter resolution of vessel wall morphology and plaque composition, enabling accurate stent sizing, optimization, and assessment of lesion morphology during percutaneous coronary and peripheral interventions. Together, these modalities are redefining procedural workflows by enabling physiology-guided, image-driven decision making that improves outcomes and shortens procedure times. As minimally invasive structural therapies proliferate, demand for integrated imaging platforms that combine ICE, IVUS, and adjunctive modalities will intensify.

Technical innovation is driving deeper clinical utility. Advances in high-frequency transducers, catheter miniaturization, and adaptive beamforming are improving spatial resolution while reducing catheter profiles-facilitating access to tortuous anatomy. Software advances such as fusion imaging, automated plaque quantification, and 3D reconstruction are transforming raw data into actionable metrics for interventionalists. Additionally, onboard AI algorithms are beginning to assist in real-time tissue characterization, segmentation, and guidance cues, reducing inter-operator variability and accelerating intra-procedural decisions. Integration with catheter lab information systems and interoperability with robotic navigation platforms will further anchor ICE/IVUS as critical components of the modern hybrid operating environment.

Commercial expansion will be propelled by evidence generation and expanded indications. As registries and randomized studies quantify reductions in radiation exposure, procedural complications, and long-term restenosis when ICE/IVUS is applied judiciously, adoption across tertiary and community centers will broaden. Cost-benefit models that incorporate reduced re-interventions and faster recovery will support payer acceptance, while training curricula evolve to upskill interventional cardiologists and cath lab teams. Opportunities also exist in tele-mentoring and remote interpretation services, where expert review of intravascular imaging can extend advanced care to underserved regions. Overall, ICE and IVUS are positioned to move from niche adjuncts to standard-of-care imaging tools enabling safer, more effective endovascular and structural heart therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Electrophysiology Procedures
  • Left Atrial Appendage Closure
  • Septal Defects
  • Others

By End-Use

  • Hospitals
  • Catheterization Laboratories
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, Boston Scientific Corporation, Johnson Johnson Services Inc Biosense Webster Inc, Nipro Infraredx Inc, Conavi Medical, Siemens Healthineers AG, Koninklijke Philips NV, GE HealthCare, Medtronic plc, Canon Medical Systems Corp
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Electrophysiology Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Left Atrial Appendage Closure Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Septal Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Application
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Application
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Application
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Application
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Application
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Abbott Laboratories
    • 8.2.2 Boston Scientific Corporation
    • 8.2.3 Johnson & Johnson Services Inc. (Biosense Webster Inc.)
    • 8.2.4 Nipro (Infraredx Inc.)
    • 8.2.5 Conavi Medical
    • 8.2.6 Siemens Healthineers AG
    • 8.2.7 Koninklijke Philips N.V
    • 8.2.8 GE HealthCare
    • 8.2.9 Medtronic Plc
    • 8.2.10 Canon Medical Systems Corp